Cargando…

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

BACKGROUND: Advanced glycation end products (AGE)-receptor for AGE (RAGE) axis and renin-angiotensin system (RAS) play a role in diabetic nephropathy (DN). Matrix metalloproteinase-2 (MMP-2) activation also contributes to DN. However, the pathological interaction among AGE-RAGE, RAS and MMP-2 in DN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukami, Kei, Yamagishi, Sho-ichi, Coughlan, Melinda T, Harcourt, Brooke E, Kantharidis, Phillip, Thallas-Bonke, Vicki, Okuda, Seiya, Cooper, Mark E, Forbes, Josephine M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138378/ https://www.ncbi.nlm.nih.gov/pubmed/25143788 http://dx.doi.org/10.1186/1758-5996-6-86

Ejemplares similares

Tandem Inhibition of PKC in Diαβetic Nephropathy: It Takes Two to Tango?
por: Thallas-Bonke, Vicki, et al.
Publicado: (2013)

Nox‐4 deletion reduces oxidative stress and injury by PKC‐α‐associated mechanisms in diabetic nephropathy
por: Thallas‐Bonke, Vicki, et al.
Publicado: (2014)

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy
por: Herman-Edelstein, Michal, et al.
Publicado: (2011)

Involvement of Iron-Evoked Oxidative Stress in Smoking-Related Endothelial Dysfunction in Healthy Young Men
por: Fukami, Kei, et al.
Publicado: (2014)

Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients
por: Fukami, Kei, et al.
Publicado: (2014)

RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice
por: Taguchi, Kensei, et al.
Publicado: (2018)

Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients
por: Koike, Kiyomi, et al.
Publicado: (2016)

Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion
por: Zhuang, Aowen, et al.
Publicado: (2019)

MicroRNA in Diabetic Nephropathy: Renin Angiotensin, AGE/RAGE, and Oxidative Stress Pathway
por: Hagiwara, Shinji, et al.
Publicado: (2013)

DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
por: Kaida, Yusuke, et al.
Publicado: (2013)

Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
por: Takeuchi, Masayoshi, et al.
Publicado: (2010)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

RAGE signaling regulates the progression of diabetic complications
por: Taguchi, Kensei, et al.
Publicado: (2023)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Yamagishi, Sho-ichi
Publicado: (2013)

Processed foods drive intestinal barrier permeability and microvascular diseases
por: Snelson, Matthew, et al.
Publicado: (2021)

Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
por: Simonyi, Gábor, et al.
Publicado: (2016)

Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients
por: Yamagishi, Sho-ichi, et al.
Publicado: (2016)

Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction
por: Sotokawauchi, Ami, et al.
Publicado: (2020)

Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE
por: Matsui, Takanori, et al.
Publicado: (2015)

Advanced glycation end products, oxidative stress and diabetic nephropathy
por: Yamagishi, Sho-ichi, et al.
Publicado: (2010)

Advanced Glycation End Products Are Direct Modulators of β-Cell Function
por: Coughlan, Melinda T., et al.
Publicado: (2011)

Ramipril: Angioedema: case report
Publicado: (2021)

Long-Term Local Injection of RAGE-Aptamer Suppresses the Growth of Malignant Melanoma in Nude Mice
por: Nakamura, Nobutaka, et al.
Publicado: (2019)

Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
por: Ishibashi, Yuji, et al.
Publicado: (2014)

Efficacy of Combination Therapy with Telmisartan Plus Amlodipine in Patients with Poorly Controlled Hypertension
por: Bekki, Hisatoshi, et al.
Publicado: (2010)

The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes
por: Snelson, Matthew, et al.
Publicado: (2022)

Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury
por: Nakayama, Yosuke, et al.
Publicado: (2014)

Ramipril poisoning rescued by naloxone and terlipressin
por: Samanta, Samanta, et al.
Publicado: (2014)

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011)

Formulation and Evaluation of Solid Lipid Nanoparticles of Ramipril
por: Ekambaram, P, et al.
Publicado: (2011)

RP-HPLC Estimation of Ramipril and Telmisartan in Tablets
por: Kurade, V. P., et al.
Publicado: (2009)

Ramipril: Aggravation of liver toxicity: case report
Publicado: (2020)

Ramipril in High-Risk Patients With COVID-19
por: Amat-Santos, Ignacio J., et al.
Publicado: (2020)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide
por: Tan, Sih Min, et al.
Publicado: (2021)

Ramipril can alleviate the accumulation of renal mesangial matrix in rats with diabetic nephropathy by inhibiting insulin-like growth factor-1
por: Ren, Wei, et al.
Publicado: (2019)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

Effect of ramipril on renal function in patients with intermittent claudication
por: Hobbs, Simon D, et al.
Publicado: (2008)

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?
por: Rahman, Sayeeda, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_j0jlrpluakckilj5mdps92n30e